Chesley Taft & Associates’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,000
Closed -$458K 287
2022
Q2
$458K Buy
30,000
+675
+2% +$12.1K 0.03% 231
2022
Q1
$596K Hold
29,325
0.03% 221
2021
Q4
$693K Buy
29,325
+325
+1% +$6.96K 0.04% 210
2021
Q3
$582K Buy
29,000
+200
+0.7% +$4.1K 0.03% 219
2021
Q2
$579K Hold
28,800
0.03% 219
2021
Q1
$629K Hold
28,800
0.04% 205
2020
Q4
$628K Sell
28,800
-175
-0.6% -$3.41K 0.04% 195
2020
Q3
$511K Sell
28,975
-1,550
-5% -$28.8K 0.04% 196
2020
Q2
$574K Buy
30,525
+25
+0.1% +$443 0.04% 188
2020
Q1
$527K Buy
+30,500
New +$638K 0.05% 184

Other funds holding MPT

Chesley Taft & Associates's MPT Position: Q3 2022 in Review

Chesley Taft & Associates sold out of Medical Properties Trust (MPT) in Q3 2022, closing a stake of 30,000 shares — an estimated $458K sold.

Chesley Taft & Associates first reported a position in MPT in Q1 2020 and held it in 10 quarters. The position peaked at $693K in Q4 2021. 600 funds tracked by Wall St. Rank hold MPT as of Q3 2022.

  • Chesley Taft & Associates reported no remaining Medical Properties Trust position as of Q3 2022 after selling out during the quarter.
  • Chesley Taft & Associates sold 30,000 Medical Properties Trust shares in Q3 2022, an estimated $458K.
  • Chesley Taft & Associates first reported a position in Medical Properties Trust in Q1 2020 and held it in 10 quarters.
  • Chesley Taft & Associates's Medical Properties Trust position peaked at $693K in Q4 2021.
  • 600 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2022.

Based on Chesley Taft & Associates's 13F filing for Q3 2022, filed 13 Oct 2022.